Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ion Beam Applications's revenue per share for the
six
months ended in Dec. 2025 was $11.88.
Ion Beam Applications's revenue per share for the trailing twelve months (TTM) ended in Dec. 2025 was $23.80.
During the past 12 months, the average Revenue Per Share Growth Rate of Ion Beam Applications was 21.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 19.60% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 15.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 7.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Ion Beam Applications's Revenue per Share or its related term are showing as below:
IOBCF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -17.7 Med: 2.4 Max: 36.6
Current: 19.6
During the past 13 years, Ion Beam Applications's highest 3-Year average Revenue Per Share Growth Rate was 36.60% per year. The lowest was -17.70% per year. And the median was 2.40% per year.
IOBCF's 3-Year Revenue Growth Rate is ranked better than 83.69% of 754
companies
in the Medical Devices & Instruments industry
Industry Median: 3.8
vs IOBCF: 19.60
Ion Beam Applications (OTCPK:IOBCF) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Ion Beam Applications Revenue per Share Related Terms
Ion Beam Applications Revenue per Share Historical Data
* Premium members only.
The historical data trend for Ion Beam Applications's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOBCF vs ABT, SYK, MDT: Revenue per Share Comparison
For the Medical Devices subindustry, Ion Beam Applications's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's PS Ratio falls into.
Ion Beam Applications Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Ion Beam Applications's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $23.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications (IOBCF) has a Revenue per Share of $23.80 as of Dec. 2025. Revenue per share equals the per-share value of a company's sales. View historical data on Ion Beam Applications and its competitors. According to the industry distribution chart, Ion Beam Applications ranks #123 out of 754 companies in the Medical Devices & Instruments industry, placing it in the top 16.3%.
Is Ion Beam Applications' Revenue per Share too high?
Ion Beam Applications' current Revenue per Share is $23.80. The Medical Devices & Instruments industry median Revenue per Share is 3.80. Ion Beam Applications' value of $23.80 is 526.3% above this industry median. Based on the distribution chart, Ion Beam Applications ranks #123 out of 754 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Revenue per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #123 out of 754 companies for Revenue per Share. This places Ion Beam Applications in the top 16% of its industry — outperforming the majority of peers. The industry median Revenue per Share is 3.80. Ion Beam Applications' value of $23.80 is 526.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.80, based on 754 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current Revenue per Share of $23.80 is 526.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current Revenue per Share is $23.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.67, compared to a current price of $17.93 — trading 4% below its estimated fair value. The current Revenue per Share is $23.80 and 526.3% above the Medical Devices & Instruments industry median of 3.80. Ion Beam Applications' overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Revenue per Share is $23.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued.
The current stock price of $17.93 is trading 4% below its estimated GF Value™ of $18.67.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
Revenue per Share: $23.80
GF Value™: $18.67 vs. price of $17.93 (4% below fair value)
Industry Position: 526.3% above the Medical Devices & Instruments median (#123 of 754)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
